Move forward with PAS 2090-compliant pharma LCA

Our Pharma LCA Implementation Services take you from roadmap to results: we develop your implementation plan, train your team, build your methodology, have it certified and support you with the calculations.

 

Build the capability in-house with our support, or let Carbon Minds conduct the assessment for you.

WHY NOW?

Pharma LCA requirements are becoming concrete

Pharma-specific product category rules are now in place, and environmental data is moving into pharmaceutical procurement. Companies need to understand what these requirements mean for their LCA approach.

PAS 2090

Pharma-specific product category rules

Published in November 2025, PAS 2090 provides product category rules for environmental life cycle assessments of pharmaceutical products.

France

Environmental criteria in public procurement

The Score Carbone Médicament has been introduced as a public methodology to support the environmental comparison of offers for the same medicine. In addition, environmental criteria have been mandatory in all new French public tenders since August 2026.

United Kingdom

The NHS supplier roadmap progresses

The NHS expands its global emissions reporting requirements from April 2027 and plans requirements for carbon footprinting of individual products from April 2028.

What this means for your company

Different goals require different setups

Data, methodology and reporting requirements depend on what your LCA needs to support.

Different starting positions

Existing data, methods, tools and internal expertise determine the right next step.

Make the right build-or-buy decision

Clarify what to develop in-house and where external support adds value before you scale.

WHAT IS PAS 2090?

A solid foundation for pharma LCA

PAS 2090:2025 is a standard developed specifically for the requirements of pharmaceutical products. It sets product category rules for environmental life cycle assessments across the full life cycle of a medicine.

Sponsored by NHS England, the UK Office for Life Sciences and the Pharmaceutical LCA Consortium, it was developed in a multi-stakeholder consensus process with input from pharmaceutical manufacturers, health systems, regulators and academia and published by BSI in November 2025.

KEY CHALLENGES

Why pharma LCA can be challenging

Turning pharma LCA requirements into a consistent, scalable process requires the right expertise, reliable data and well-defined calculation rules.

01

Limited in-house expertise

Pharma LCA requires both methodological knowledge and an understanding of industry-specific requirements. Building this expertise takes time – from assessing data quality and supplier information to interpreting and communicating results.

02

Fragmented and missing data

Data on APIs, excipients, packaging and manufacturing is often spread across different systems and departments. Supplier data can be limited, and representative data for pharma-specific substances may not be available.

03

Scaling LCA across your portfolio

Complex product portfolios, multiple sites and suppliers, different data sources and methodological requirements make consistency difficult. The challenge is to establish an approach that can be repeated, updated and scaled across your portfolio.

HOW WE CAN HELP

Start where you are.

You do not need every service or have to start with the Starter Package. The Discovery Call helps identify the right next step

Start with a clear roadmap

Starter Package

Get your stakeholders on one page and decide how to implement PAS 2090: build in-house, outsource the calculations, or combine both.

€2,300*

Included

Build the foundations

Training & Company Methodology

Build the know-how and the rules your team needs for consistent, verifiable results. Each module can be booked on its own.

Training for Pharma LCA
Starting at 2,500€

Company methodology
Get a quote

Scope

Calculate your first LCAs

Pilot Project

Calculate LCAs for your most important products while building the process you will later scale.

Get a quote

Scope

Scale across your portfolio

Portfolio Rollout

Move from individual pilot calculations to consistent LCA results across all relevant products.

Get a quote

Scope

Pilot: access to Carbon Minds data is required for both routes. *Indicative prices.

Discuss your goals, current challenges and existing LCA work with our experts to identify the next step. You do not need to choose a service before the call.

Build in-house or let Carbon Minds do it for you

Build in-house

Your team runs the LCAs. We provide data, training and expert support as needed.

Done for you by Carbon Minds

We collect the required inputs, perform the calculations and deliver the results.

YOUR PHARMA EXPERT

Dr. Leif Rohrbach

Project & Pharma Lead

Leif leads our activities in the pharmaceutical sector and supports companies from initial LCA strategy to implementation, combining pharmaceutical sustainability requirements with our expertise in chemical value chains.

 

Good data is essential for assessments, to facilitate discussions with suppliers, and to capture the impact of reductions.

Jens Plambeck,

Senior Manager Supplier Decarbonization

Bayer

FAQ

Who are the pharma LCA Implementation Services for?

The package is designed for pharmaceutical companies that are starting or expanding product-level LCA activities, particularly MAHs and generic, specialty and virtual pharma companies working with outsourced small-molecule manufacturing.

Is PAS 2090 mandatory?

PAS 2090 is a voluntary BSI standard, not a law. It aims to improve the quality and consistency of environmental reporting on medicines, helping manufacturers respond to information requests from healthcare providers, investors and other stakeholders.

Why start with strategic alignment?

Pharma LCA needs budget, management support and data from many departments – from procurement to manufacturing and packaging. Before calculating, you need clarity on the objective, the required consistency, the methodology, realistic data granularity and what to build internally versus have done externally. Otherwise, teams collect large amounts of data without knowing what they really need. 

We already have calculations or tools – can we build on them?

Yes. During strategic alignment, we review your existing calculations or tools and identify any changes needed to meet new requirements. Together, we define how to build on your existing work rather than start from scratch.

What information do I need to provide for the initial data mapping, and how is data availability assessed?

For the initial data mapping, start with a list of your raw materials and their CAS numbers. During strategic alignment, we map this list against the Carbon Minds database to identify available datasets and remaining gaps. PAS 2090 accommodates different levels of data maturity and does not require primary data for activities outside your operational control.

Do we need to book all four services?

No. You choose the servies you need. The Starter Package is a strategic alignment service designed as a starting point to decide on your next steps. All Steps can be booked on its own.

Is the methodology behind Carbon Minds data certified?

Yes. The Carbon Minds database is built on a methodology certified by TÜV Rheinland for compliance with ISO 14040, ISO 14044 and ISO 14067, as well as additional standards and guidelines, including the Together for Sustainability (TfS) PCF Guideline, WBCSD and the GHG Protocol Product Life Cycle Standard. The methodology also supports compliance with PAS 2090:2025.

Discuss your next step in pharma LCA

Discuss your goals, current challenges and existing LCA work with our experts to identify the next step. You do not need to choose a service before the call.

Get in touch

Are you looking for better life cycle data? Evidence-based decision support? Executive training? Or something else?

Use this form to tell us what you’re interested in.